Neural Operant Conditioning

Sponsor
MetroHealth Medical Center (Other)
Overall Status
Recruiting
CT.gov ID
NCT06113965
Collaborator
(none)
60
1
1
48
1.3

Study Details

Study Description

Brief Summary

The goal of this clinical trial is to learn if operant conditioning can reduce spasticity in order to improve walking in stroke patient. The main questions it aims to answer are:

  • Can participants self-regulate reflex excitability

  • Can participants self-regulate reflex, reduce spasticity and improve walking Participants will undergo surface stimulation to evoke spinal reflexes and will be asked to control these reflexes therefore reducing spasticity.

Researchers will compare result to able bodied participants to see if [insert effects]

Condition or Disease Intervention/Treatment Phase
  • Other: Peripheral Nerve Stimulation
N/A

Detailed Description

The study purpose is to investigate the possibility and later effect of spinal reflex self-regulation in post-stroke stiff-knee gait. The intervention will consist of direct current surface stimulation of the peripheral nerves using electrical stimulation. Stimulation will evoke a motor response that will be collected through surface EMG electrodes and processed to depict a measure of the response as feedback to the participant to complete the loop of operant conditioning. The participant will attempt to modulate their responses over multiple sessions to cause this depiction to either increase or decrease its value depending on an established target.

.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Neural Operant Conditioning to Improve Walking After Stroke
Anticipated Study Start Date :
May 31, 2024
Anticipated Primary Completion Date :
May 31, 2027
Anticipated Study Completion Date :
May 31, 2028

Arms and Interventions

Arm Intervention/Treatment
Experimental: Experimental: Post-stroke Stiff-Knee Gait Participants

Individuals with post-stroke Stiff-Knee gait

Other: Peripheral Nerve Stimulation
Electrical stimulation of peripheral nerves to measure resulting gait kinematics and surface muscle activity

Outcome Measures

Primary Outcome Measures

  1. Surface electromyographic recording of leg muscles [baseline, week 6 -mid-treatment, week 12 - end of treatment, 4-week post treatment, 12 weeks post treatment, 24 weeks post treatment]

    Recording electrical activity of leg muscles during walking in response to peripheral nerve stimulation

Secondary Outcome Measures

  1. 10 meter walk test [baseline, week 6 -mid-treatment, week 12 - end of treatment, 4-week post treatment, 12 weeks post treatment, 24 weeks post treatment]

    10 meter walk test with collection of gait kinematics captured using an inertial motion capture camera system

  2. quadriceps pendulum test [baseline, week 6 -mid-treatment, week 12 - end of treatment, 4-week post treatment, 12 weeks post treatment, 24 weeks post treatment]

    This is a method of evaluating spasticity using gravity to provoke the muscular stretch reflex allowing for the collection of joint angle data. This data will aid in assessing changes in joint angles as a result of training.

  3. Five Times Sit to Stand Test [baseline, week 6 -mid-treatment, week 12 - end of treatment, 4-week post treatment, 12 weeks post treatment, 24 weeks post treatment]

    measures lower extremity functional strength. This test will measure your leg strength by asking you to sit down and stand up from a chair 5 times as fast as possible.

  4. TMS [Baseline, Week 12 - end of treatment]

    non-invasive brain stimulation device, will be used to elicit a motor evoked response in participants via low frequency stimulation to the cortical regions associated with the muscles being investigated. This approach will test the integrity of the participant's CST in relation to the intervention and assessments being conducted

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  1. Sign and date consent form

  2. At least 3 months since stroke event

  3. Over 18 years of age at time of eligibility

  4. Ability to stand upright and walk for at least 5 minutes

  5. Premorbidly independent

  6. Mild to moderate gait impairment

  7. Reduced knee flexion during walking relative to the unimpaired side

  8. Unilateral hemiparesis of the lower limbs

  9. Ability to evoke muscle responses through peripheral nerve stimulation, spinal cord stimulation, and transcranial magnetic stimulation

  10. Medically stable

  11. Skin intact on hemiparetic leg, abdomen, and scalp

  12. Ability to evoke muscle responses and/or reflex responses through peripheral nerve stimulation, spinal cord stimulation, and/or transcranial magnetic stimulation

Exclusion Criteria:
  1. Co-existing neurological condition other than prior stroke involving the hemiparetic lower limb (e.g., peripheral nerve injury, PD, SCI, TBI, MS).

  2. History of lower limb musculoskeletal injury

  3. Functionally relevant osteoarthritis and weight bearing restriction

  4. Functionally relevant polyneuropathy resulting in lack of sensation in the lower leg

  5. Functionally relevant cognitive impairment

  6. Functionally relevant vision impairment

  7. Pregnant

  8. Botox injection to the ipsilateral leg in the last 12 weeks or taking oral anti-spasticity medications

  9. Taking part in physical therapy for any walking-related impairment

  10. Cardiac pacemaker or other implanted electronic systems

  11. Uncontrolled seizure disorder

  12. Use of seizure lowering threshold medications and the discretion of the study physician

  13. Deficits in communication that interfere with reasonable study participation

  14. Severely impaired cognition and communication

  15. Severe lower limb pain

Contacts and Locations

Locations

Site City State Country Postal Code
1 MetroHealth Medical Center Cleveland Ohio United States 44109

Sponsors and Collaborators

  • MetroHealth Medical Center

Investigators

  • Principal Investigator: James Sulzer, PhD, MetroHealth Medical Center

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
James Sulzer, James Sulzer, PhD, MetroHealth Medical Center
ClinicalTrials.gov Identifier:
NCT06113965
Other Study ID Numbers:
  • StudyID00000301
First Posted:
Nov 2, 2023
Last Update Posted:
Nov 2, 2023
Last Verified:
Oct 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 2, 2023